Oncology
 |
|
20 december 2018 21:00:10 |
| PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study (British Journal of Cancer) |
|
Tweet |
| 76 viewsCategory: Oncology |
 New high-risk molecular subtypes of DLBCL identified (Nature Clinical Practice Oncology)Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
